Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Publikováno v:
Value in Health. 23:1543-1551
Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral sclerosis (ALS) in light of recent advances in disease staging and understanding of stage-specific drug effect. Methods ALS was staged according to the “fin
Autor:
Steven Deitelzweig, François Laliberté, R Raut, William H. Olson, Guillaume Germain, Patrick Lefebvre, Jeffrey Schein, Brahim Bookhart
Publikováno v:
Value in Health. 19:A45-A46
Autor:
Michael E Carson, Patrick Hlavacek, Alan G. White, Carl L. Roland, Mihran Ara Yenikomshian, Gary M. Oderda, Louis P. Garrison, Joseph Biskupiak
Publikováno v:
Value in Health. 19:A247
Objectives: To estimate healthcare resource utilization, associated costs, and number needed to harm (NNH) from a physician's decision to prescribe extended-release (ER) non-abuse-deterrent opioids (non-ADO) as compared to ER ADOs in a chronic pain p
Autor:
Robert Hiscock, F. Zhang
Publikováno v:
Value in Health. 17:A285
Publikováno v:
Value in Health. 4:123-124
OBJECTIVE: To assess the economic outcome, from a health care budget perspective, of treating Crohn's disease (CD) patients with budesonide controlled ileal release (CIR) 6 mg per day as maintenance therapy compared to no maintenance therapy (NMT). M
Publikováno v:
Value in Health. 4:123
BACKGROUND: Economic aspects are important when assessing the overall benefit of a treatment strategy. The number of investigations of these aspects are few within the field of Crohn's disease (CD). OBJECTIVE: To assess the economic consequences, fro